Площадка "Управление персоналом ..." |
| Вопрос от Bradly добавлен 22-12 07:29 |
|
I want to make a withdrawal http://keandra.in.net/ keandra.com The researchers found that the 10-year biochemical recurrence-free survival was 42.9%, 25.1%, and 28.6% for patients who had biopsy Gleason 8, 9, and 10 tumors, respectively. The 10-year clinical progression-free survival was 70.7%, 47.2%, and 25%, respectively. The 10-year cancer-specific survival was 84.9%, 66.1%, and 50%. After adjusting for preoperative PSA level, clinical T stage, and age, men with a biopsy Gleason score of 9 and 10 had an approximately 2.5 and 4.0 times higher risk for clinical progression and cancer-related death compared with men who had a biopsy Gleason score of 8.
|
| Ответ |
|
|
| *Имя: | E-mail: |
| *Тема: | |
*Вопрос:
|
|
|
| Предыдущий вопрос
Список вопросов
Следующий вопрос
|
